Aspira Women's Health Inc. (AWHL) Fair Value 2026

AWHL · Diagnostics & Research ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.4 /10

32 fundamental signals · 0 models active

Value Trap Risk

LOW (39/100)

Quick Summary — As of 2026-08-27, Aspira Women's Health Inc. (AWHL) trades at $0.26. QOC: 6.4/10. Value Trap Risk: 39/100 (LOW). 0/13 models active.

Key Facts

Ticker
AWHL
Price
$0.26
Quality Score
6.4/10
Value Trap Risk
39/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Limited model coverage (0/13) may reduce confidence

What Fair Value Does Each Model Give AWHL?

0 Intrinsic Value Models vs. Current Price ($0.26)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is Aspira Women's Health Inc. (AWHL) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Aspira Women's Health Inc. currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About AWHL?

0 of 13 models are currently active for AWHL. See which stocks rank higher →

How Does AWHL Rank in Diagnostics & Research?

Among 52 Diagnostics & Research stocks, AWHL ranks #34 by Quality of Company score. CirclFi's QOC score of 6.4/10 evaluates 32 fundamental signals. A score of 6.4 indicates above-average quality.

The Diagnostics & Research sector introduces analytical considerations specific to pharmaceutical industry businesses. For Aspira Women's Health Inc., metrics like pipeline depth and stage distribution provide important context that general-purpose valuation models may underweight.

Is AWHL a Value Trap?

CirclFi's Value Trap algorithm assigns AWHL a score of 39/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for Aspira Women's Health Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Aspira Women's Health Inc. scores 6.4 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every AWHL valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Aspira Women's Health Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Diagnostics & Research Stocks Should You Also Analyze?

11 related Diagnostics & Research stocks with 13-model coverage

PSNLPersonalis, Inc.QOC 6.4BDSXBiodesix, Inc.QOC 6.3WGSGeneDx Holdings Corp.QOC 6.4GRALGRAIL, Inc.QOC 6.2BNRBurning Rock Biotech LimitedQOC 6.5IMDXInsight Molecular Diagnostics Inc.QOC 6.1NDRAENDRA Life Sciences Inc.QOC 4.0IDXGInterpace Biosciences, Inc.QOC 8.2CDNACareDx, Inc.QOC 7.3IDXXIDEXX Laboratories, Inc.QOC 9.5MEDPMedpace Holdings, Inc.QOC 9.3

Read investment analysis: PSNL · BDSX · WGS · GRAL · BNR · IMDX · NDRA · IDXG · CDNA · IDXX · MEDP

Which Other Stocks Have a Similar Quality Score to AWHL?

7 companies across all industries closest to AWHL’s Quality of Company score of 6.4/10.

SXCSunCoke Energy, Inc.QOC 6.4AVALGrupo Aval Acciones y Valores S.A.QOC 6.4ARLAmerican Realty Investors, Inc.QOC 6.4TDSTelephone and Data Systems, Inc.QOC 6.4UCTTUltra Clean Holdings, Inc.QOC 6.4KROKronos Worldwide, Inc.QOC 6.4NVDANVIDIA CorporationQOC 10.0

Read investment analysis: SXC · AVAL · ARL · TDS · UCTT · KRO · NVDA

What Else Do Investors Ask About Aspira Women's Health Inc.’s Valuation?

What is Aspira Women's Health Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Aspira Women's Health Inc. (AWHL). The Quality of Company score is 6.4/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is AWHL overvalued or undervalued right now?

At $0.26, 0 of 0 active models suggest AWHL may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Aspira Women's Health Inc.'s business model in Diagnostics & Research.

What does a Quality of Company score of 6.4 mean for AWHL?

Aspira Women's Health Inc.'s QOC of 6.4/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on AWHL?

CirclFi analyzes AWHL with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is AWHL a value trap in 2026?

Aspira Women's Health Inc.'s Value Trap score is 39/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Aspira Women's Health Inc. (AWHL) a Quality of Company score of 6.4/10 across 32 fundamental signals as of 2026-08-27.” Source: circlfi.com/stock/AWHL/ · Methodology
Primary sources for this AWHL valuation
  • Financial statements: Aspira Women's Health Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0000926617) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for AWHL as of ; valuations recomputed .